Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2000 | 2392 | 44.9 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
566 | 2 | EPOXYEICOSATRIENOIC ACIDS//LIPOXYGENASE//LEUKOTRIENES | 14430 |
2000 | 1 | EPOXYEICOSATRIENOIC ACIDS//SOLUBLE EPOXIDE HYDROLASE//20 HYDROXYEICOSATETRAENOIC ACID | 2392 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EPOXYEICOSATRIENOIC ACIDS | authKW | 3047284 | 13% | 79% | 302 |
2 | SOLUBLE EPOXIDE HYDROLASE | authKW | 2416206 | 9% | 86% | 221 |
3 | 20 HYDROXYEICOSATETRAENOIC ACID | authKW | 1029301 | 4% | 81% | 100 |
4 | 20 HETE | authKW | 964150 | 4% | 79% | 96 |
5 | EETS | authKW | 540824 | 2% | 85% | 50 |
6 | DIHYDROXYEICOSATRIENOIC ACID | authKW | 408442 | 1% | 100% | 32 |
7 | CYP2J2 | authKW | 388290 | 2% | 82% | 37 |
8 | EPOXYGENASE | authKW | 310923 | 2% | 59% | 41 |
9 | SEH | authKW | 300149 | 1% | 87% | 27 |
10 | SOLUBLE EPOXIDE HYDROLASE INHIBITOR | authKW | 259689 | 1% | 88% | 23 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 5501 | 15% | 0% | 349 |
2 | Physiology | 3890 | 15% | 0% | 349 |
3 | Biochemistry & Molecular Biology | 3116 | 32% | 0% | 773 |
4 | Pharmacology & Pharmacy | 2433 | 20% | 0% | 490 |
5 | Biophysics | 990 | 8% | 0% | 200 |
6 | Cardiac & Cardiovascular System | 964 | 9% | 0% | 217 |
7 | Cell Biology | 755 | 11% | 0% | 262 |
8 | Chemistry, Medicinal | 368 | 4% | 0% | 106 |
9 | Urology & Nephrology | 315 | 4% | 0% | 98 |
10 | Endocrinology & Metabolism | 237 | 5% | 0% | 122 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UCD CANC | 131417 | 1% | 47% | 22 |
2 | UC DAVIS COMPREHENS CANC | 112295 | 1% | 40% | 22 |
3 | VASC SIGNALLING GRP | 106352 | 1% | 56% | 15 |
4 | INTRAMURAL | 102450 | 4% | 8% | 104 |
5 | SW MED MOLEC GENET | 88294 | 1% | 43% | 16 |
6 | UCD COMPREHENS CANC | 70026 | 1% | 37% | 15 |
7 | ENTOMOL CANC | 69489 | 0% | 78% | 7 |
8 | VASC SIGNALLING | 55112 | 1% | 24% | 18 |
9 | PULM PATHOBIOL | 51167 | 1% | 21% | 19 |
10 | KARDIOVASK PHYSIOL | 48510 | 1% | 22% | 17 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 58450 | 4% | 5% | 91 |
2 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 8481 | 1% | 3% | 23 |
3 | HYPERTENSION | 8303 | 4% | 1% | 87 |
4 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 7317 | 4% | 1% | 85 |
5 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 5388 | 2% | 1% | 53 |
6 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 4458 | 3% | 0% | 78 |
7 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 3574 | 3% | 0% | 78 |
8 | DRUG METABOLISM AND DISPOSITION | 2266 | 2% | 0% | 37 |
9 | JOURNAL OF LIPID RESEARCH | 2216 | 2% | 0% | 39 |
10 | AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY | 1951 | 2% | 0% | 37 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPOXYEICOSATRIENOIC ACIDS | 3047284 | 13% | 79% | 302 | Search EPOXYEICOSATRIENOIC+ACIDS | Search EPOXYEICOSATRIENOIC+ACIDS |
2 | SOLUBLE EPOXIDE HYDROLASE | 2416206 | 9% | 86% | 221 | Search SOLUBLE+EPOXIDE+HYDROLASE | Search SOLUBLE+EPOXIDE+HYDROLASE |
3 | 20 HYDROXYEICOSATETRAENOIC ACID | 1029301 | 4% | 81% | 100 | Search 20+HYDROXYEICOSATETRAENOIC+ACID | Search 20+HYDROXYEICOSATETRAENOIC+ACID |
4 | 20 HETE | 964150 | 4% | 79% | 96 | Search 20+HETE | Search 20+HETE |
5 | EETS | 540824 | 2% | 85% | 50 | Search EETS | Search EETS |
6 | DIHYDROXYEICOSATRIENOIC ACID | 408442 | 1% | 100% | 32 | Search DIHYDROXYEICOSATRIENOIC+ACID | Search DIHYDROXYEICOSATRIENOIC+ACID |
7 | CYP2J2 | 388290 | 2% | 82% | 37 | Search CYP2J2 | Search CYP2J2 |
8 | EPOXYGENASE | 310923 | 2% | 59% | 41 | Search EPOXYGENASE | Search EPOXYGENASE |
9 | SEH | 300149 | 1% | 87% | 27 | Search SEH | Search SEH |
10 | SOLUBLE EPOXIDE HYDROLASE INHIBITOR | 259689 | 1% | 88% | 23 | Search SOLUBLE+EPOXIDE+HYDROLASE+INHIBITOR | Search SOLUBLE+EPOXIDE+HYDROLASE+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | IMIG, JD , (2012) EPOXIDES AND SOLUBLE EPOXIDE HYDROLASE IN CARDIOVASCULAR PHYSIOLOGY.PHYSIOLOGICAL REVIEWS. VOL. 92. ISSUE 1. P. 101-130 | 273 | 84% | 114 |
2 | ROMAN, RJ , (2002) P-450 METABOLITES OF ARACHIDONIC ACID IN THE CONTROL OF CARDIOVASCULAR FUNCTION.PHYSIOLOGICAL REVIEWS. VOL. 82. ISSUE 1. P. 131 -185 | 286 | 60% | 792 |
3 | WESTPHAL, C , KONKEL, A , SCHUNCK, WH , (2015) CYTOCHROME P450 ENZYMES IN THE BIOACTIVATION OF POLYUNSATURATED FATTY ACIDS AND THEIR ROLE IN CARDIOVASCULAR DISEASE.MONOOXYGENASE, PEROXIDASE AND PEROXYGENASE PROPERTIES AND MECHANISMS OF CYTOCHROME P450. VOL. 851. ISSUE . P. 151 -187 | 227 | 82% | 4 |
4 | SPECTOR, AA , KIM, HY , (2015) CYTOCHROME P-450 EPOXYGENASE PATHWAY OF POLYUNSATURATED FATTY ACID METABOLISM.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1851. ISSUE 4. P. 356 -365 | 146 | 92% | 16 |
5 | FLEMING, I , (2014) THE PHARMACOLOGY OF THE CYTOCHROME P450 EPOXYGENASE/SOLUBLE EPOXIDE HYDROLASE AXIS IN THE VASCULATURE AND CARDIOVASCULAR DISEASE.PHARMACOLOGICAL REVIEWS. VOL. 66. ISSUE 4. P. 1106 -1140 | 244 | 58% | 19 |
6 | FAN, F , GE, Y , LV, WS , ELLIOTT, MR , MUROYA, Y , HIRATA, T , BOOZ, GW , ROMAN, RJ , (2016) MOLECULAR MECHANISMS AND CELL SIGNALING OF 20-HYDROXYEICOSATETRAENOIC ACID IN VASCULAR PATHOPHYSIOLOGY.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 21. ISSUE . P. 1427 -1463 | 226 | 66% | 0 |
7 | MORISSEAU, C , HAMMOCK, BD , (2013) IMPACT OF SOLUBLE EPOXIDE HYDROLASE AND EPOXYEICOSANOIDS ON HUMAN HEALTH.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013. VOL. 53. ISSUE . P. 37-58 | 116 | 91% | 75 |
8 | IMIG, JD , HAMMOCK, BD , (2009) SOLUBLE EPOXIDE HYDROLASE AS A THERAPEUTIC TARGET FOR CARDIOVASCULAR DISEASES.NATURE REVIEWS DRUG DISCOVERY. VOL. 8. ISSUE 10. P. 794 -805 | 122 | 88% | 170 |
9 | WU, CC , GUPTA, T , GARCIA, V , DING, Y , SCHWARTZMAN, ML , (2014) 20-HETE AND BLOOD PRESSURE REGULATION CLINICAL IMPLICATIONS.CARDIOLOGY IN REVIEW. VOL. 22. ISSUE 1. P. 1 -12 | 151 | 73% | 25 |
10 | KONKEL, A , SCHUNCK, WH , (2011) ROLE OF CYTOCHROME P450 ENZYMES IN THE BIOACTIVATION OF POLYUNSATURATED FATTY ACIDS.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. VOL. 1814. ISSUE 1. P. 210-222 | 153 | 75% | 69 |
Classes with closest relation at Level 1 |